The Latest Breaking News from EC

EC bars BJP MLA from campaigning for 24 hours for MCC violation

His speech on February 18 ‘utterly irresponsible and provocative’, it says

The Hindu · Feb 22, 2022

Election Commission allows political rallies without capacity limit, road shows

COVID-10 cases have declined significantly, it says

The Hindu · Feb 22, 2022

MoEF panel seeks more info on Sitammasagar project

Govt. proposes 320 MW hydel unit at barrage with 36.57 tmc ft storage 

The Hindu · Feb 22, 2022

Uttar Pradesh elections: In third round, too, voters score 1st division; 60.8 % turnout recorded By 5pm

LUCKNOW: The third phase of Uttar Pradesh elections on Sunday saw a turnout of approximately 60% in 59 constituencies across 16 districts of three regions--west UP, Awadh and part of Bundelkhand.

The Times of India · Feb 20, 2022

Hyderabad police book BJP MLA Raja Singh for his ‘bulldozer’ remarks

EC also banned Mr. Singh from holding any public meetings, processions, rallies, road shows, interviews and public utterances in the media in connection with the ongoing elections for 72 hours

The Hindu · Feb 20, 2022

Uttar Pradesh Assembly elections | Third phase turnout over 60%

As many as 627 candidates are in the fray in this phase, in which over 2.15 crore people are eligible to vote

The Hindu · Feb 20, 2022

Campaign ends in Punjab, voting tomorrow

CHANDIGARH/BATHINDA: Campaigning for the Punjab elections drew to a close on Friday evening with senior leaders of all parties making last-ditch efforts to woo voters in the 117 constituencies of the state.

The Times of India · Feb 18, 2022

ECI gives BJP MLA who threatened U.P. voters more time to respond to notice

Residents who don’t support Adityanath would face the wrath of bulldozers, Telangana MLA said on video

The Hindu · Feb 18, 2022

Retailers face tough 2022 despite sales rebound; FTSE 100’s worst week since November; NatWest back in profit – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK · Feb 18, 2022

Global Blood Therapeutics' Oxbryta Scores European Approval For Sickle Cell Disease

The European Commission (EC) has approved Global Blood Therapeutics Inc's 

Benzinga · Feb 16, 2022